News
4d
Zacks Investment Research on MSNCVS or UnitedHealth: Which Stock Is a Better Buy Ahead of Q2 Earnings?CVS Health CVS and UnitedHealth UNH offer integrated healthcare services but their first-quarter result were quite ...
15d
Zacks Investment Research on MSNCVS Up on Medicare Advantage Strength: Is It a Buy Before Q2 Earnings?CVS Health Corporation CVS is gaining investor attention as the stock trends higher ahead of its second-quarter earnings release, scheduled for July 30, 2025. A key catalyst behind the recent uptick ...
CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it overcharged Medicare for prescription drugs.
For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...
Barclays upgrades CVS Health to Overweight, citing gains in pharmacy market share and potential upside from CostVantage. CVS is expected to recover 200 basis points in Medicare margins by 2026 ...
CVS Health hiked its 2025 forecast above Wall Street’s expectations after improving Medicare benefits contributed to a better-than-expected first quarter. The health care giant said Thursday ...
With the acquisition of CVS Health’s shared savings business, the company has providers in 40 states serving around 1 million Medicare beneficiaries, according to the release.
For 2025, Barclays estimates market forecasts include expectations of 110 basis points in Medicare margin expansion, which is on the lower end of CVS’s target range of 100-200 bps.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results